PPMD & Global Patient Advocacy Groups Award BIND Project $113,000 to Further Brain Involvement Research ...
Dyne Therapeutics Announces Positive New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne ...